KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Operating Leases (2019 - 2025)

Historic Operating Leases for Biolife Solutions (BLFS) over the last 7 years, with Q3 2025 value amounting to $13.2 million.

  • Biolife Solutions' Operating Leases fell 2665.63% to $13.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year decrease of 2665.63%. This contributed to the annual value of $12.7 million for FY2024, which is 4632.55% up from last year.
  • As of Q3 2025, Biolife Solutions' Operating Leases stood at $13.2 million, which was down 2665.63% from $13.8 million recorded in Q2 2025.
  • Biolife Solutions' 5-year Operating Leases high stood at $18.7 million for Q1 2022, and its period low was $8.7 million during Q4 2023.
  • Moreover, its 5-year median value for Operating Leases was $16.5 million (2021), whereas its average is $15.4 million.
  • In the last 5 years, Biolife Solutions' Operating Leases skyrocketed by 224370.86% in 2021 and then tumbled by 4188.61% in 2023.
  • Over the past 5 years, Biolife Solutions' Operating Leases (Quarter) stood at $16.5 million in 2021, then dropped by 9.13% to $15.0 million in 2022, then crashed by 41.89% to $8.7 million in 2023, then soared by 46.33% to $12.7 million in 2024, then grew by 3.63% to $13.2 million in 2025.
  • Its Operating Leases stands at $13.2 million for Q3 2025, versus $13.8 million for Q2 2025 and $14.0 million for Q1 2025.